ERBB2 and ovarian cancer: Thus, LDL-encapsulated cholesterol-conjugated heat shock protein 27 (HSP27) and human epidermal growth factor receptor 2 (HER2) dual inhibitor specifically targeted and inhibited ovarian cancer cells (163).